Fasciola hepatica: A cause of obstructive Jaundice in an elderly man from Iran

Saudi Journal of Gastroenterology

Volumn 14, Issue 4, 2008, Pages 208-210

  Moghadami, Mohsen ^a,c   Mardani, M ^b  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Fasciola; Iran; Jaundice; Obstruction

Indexed keywords

EID: 53849118111     PISSN: 13193767     EISSN: 19984049     Source Type: Journal    
DOI: 10.4103/1319-3767.43279     Document Type: Article

References (13)

1. Haseeb AN, el-Shazly AM, Arafa MA, Morsy AT. A review on fascioliasis in Egypt. J Egypt Soc Parasitol 2002;32:317-54.
2. Moghaddam AS, Massoud J, Mahmoodi M, et al. Human and animal fascioliasis in Mazandaran province, northern Iran. Prasitol Res 2004;94:61-9.
3. Moghaddam AS, Massoud J, Mahmoodi M, et al. Human and animal fascioliasis in Mazandaran province, northern Iran. Parasitol Res 2004;94:61-9.
4. Chan CW, Lam SK. Diseases caused by liver flukes and cholangiocarcinoma. Baillieres Clin Gastroenterol 1987;1:297.
5. Adel AF. Trematodes and other flukes. In: Mandel GL, Bennet JE, Dolin R, editors. Principles and practice of infectious diseases. 5th ed. Churchill Livingstone: Philadelphia; 2000. p. 2954-6.
6. Kiladze M, Chipashvili L, Abuladze D, Jatchvliani D. Obstruction of common bile duct caused by liver fluke - Fasciola hepatica. Sb Lek 2000;101:225-9.
7. Gulsen MT, Savas MC, Koruk M, et al. Fascioliasis: A report of five cases presenting with common bile duct obstruction. Neth J Med 2006;64:17-9.
8. MacLean JD, Graeme-Cook FM. Case records of the Massachusetts General Hospital: Weekly clinicopathological exercises: Case 12-2002: A 50-year-old man with eosinophilia and fluctuating hepatic lesions. N Engl J Med 2002;346:1232-9
9. Dias LM, Silva R, Viana HL, Palhinhas M, Viana RL. Biliary fascioliasis: Diagnosis, treatment and follow-up by ERCP. Gastrointest Endos 1996;43:6169.
10. Mansour WA, Kaddah MA, Sjaker ZA, et al. A monoclonal antibody diagnoses active fasciola infection in humans. J Egypt Soc Parasitol 1998;28:711
11. Graham CS, Brodie SB, Weller PF. Imported Fasciola hepatica infection in the United States and treatment with triclabendazole. Clin Infect Dis 2001;33:1-5.
12. Millan JC, Mull R, Freise S, et al. The efficacy and tolerability of triclabendazole in Cuban patients with latent and chronic Fasciola hepatica infection. Am J Trop Med Hyg 2000;63:264-9.
13. Lecaillon JB, Godbillon J, Campestrini J, et al. Effect of food on the bioavailability of triclabendazole in patients with fascioliasis. Br J Clin Pharmacol 1998;45:601-4.